Ignite Creation Date:
2025-12-25 @ 3:17 AM
Ignite Modification Date:
2026-02-20 @ 10:44 PM
Study NCT ID:
NCT01588405
Status:
COMPLETED
Last Update Posted:
2016-05-16
First Post:
2012-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Remodulin® to Oral Treprostinil Transition
Sponsor:
United Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TDE-PH-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None